Tumor-Targeting T Cells Engineered for Controlled Growth

被引：0
|
作者：
不详
机构：
来源：
CHEMICAL ENGINEERING PROGRESS | 2010年 / 106卷 / 06期
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [21] Pancreatic Tumor-Targeting Stemsome Therapeutics
    Park, Jun-Young
    Park, Jun Young
    Jeong, Yong-Gyu
    Park, Joo-Hwan
    Park, Yeon Ho
    Kim, Sang-Hyun
    Khang, Dongwoo
    ADVANCED MATERIALS, 2023, 35 (30)
  • [22] Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer
    Tapia-Galisteo, Antonio
    Sanchez Rodriguez, Inigo
    Aguilar-Sopena, Oscar
    Lykke Harwood, Seandean
    Narbona, Javier
    Ferreras Gutierrez, Mariola
    Navarro, Rocio
    Martin-Garcia, Laura
    Corbacho, Cesareo
    Compte, Marta
    Lacadena, Javier
    Blanco, Francisco J.
    Chames, Patrick
    Roda-Navarro, Pedro
    Alvarez-Vallina, Luis
    Sanz, Laura
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [23] Improving the tumor selectivity of T cell engagers by logic-gated dual tumor-targeting
    Shen, Ying
    Jin, Shi-jie
    Chen, Yi-chang
    Liu, Wen-hui
    Li, Yi-ming
    Zhao, Wen-yi
    Xu, Ying-chun
    Chen, Shu-qing
    Zhao, Wen-bin
    PHARMACOLOGICAL RESEARCH, 2023, 192
  • [24] Genetically engineered Bifidobacterium longum expressing cytosine deaminase for tumor-targeting enzyme-prodrug therapy
    Sasaki, Takayuki
    Fujimori, Minoru
    Hamaji, Yoshinori
    Hama, Yoshihisa
    Ito, Ken-Ichi
    Amano, Jun
    Taniguchi, Shun'ichiro
    CANCER RESEARCH, 2006, 66 (08)
  • [25] Genetically engineered bacteria-mediated multi-functional nanoparticles for synergistic tumor-targeting therapy
    Wang, Yaotai
    Tang, Yu
    Du, Yan
    Lin, Li
    Zhang, Zhong
    Ou, Xia
    Chen, Sheng
    Wang, Qi
    Zou, Jianzhong
    ACTA BIOMATERIALIA, 2022, 150 : 337 - 352
  • [26] Genetically engineered bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of breast cancer.
    Fujimori, M.
    Sasaki, T.
    Hamaji, Y.
    Amano, J.
    Taniguchi, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S77 - S77
  • [27] MESOTHELIN (MSLN) TARGETING ALLOGENEIC CAR T CELLS ENGINEERED TO OVERCOME TUMOR IMMUNOSUPPRESSIVE MICROENVIRONMENT
    Schiffer-Mannioui, Cecile
    Leduc, Sophie
    Chion-Sotinel, Isabelle
    le Clerre, Diane
    Guyot, Valerie
    Rotondi, Marco
    Galetto, Roman
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A151 - A151
  • [28] Targeting Tumor Stroma Using Engineered Mesenchymal Stem Cells Reduces the Growth of Pancreatic Carcinoma
    Zischek, Christoph
    Niess, Hanno
    Ischenko, Ivan
    Conrad, Claudius
    Huss, Ralf
    Jauch, Karl-Walter
    Nelson, Peter J.
    Bruns, Christiane
    ANNALS OF SURGERY, 2009, 250 (05) : 747 - 753
  • [29] In vivo selection of tumor-targeting RNA motifs
    Mi J.
    Liu Y.
    Rabbani Z.N.
    Yang Z.
    Urban J.H.
    Sullenger B.A.
    Clary B.M.
    Nature Chemical Biology, 2010, 6 (1) : 22 - 24
  • [30] Advances on Tumor-Targeting Delivery of Cytotoxic Proteins
    Asrorov, Akmal M.
    Gu, Zeyun
    Min, Kyoung Ah
    Shin, Meong Cheol
    Huang, Yongzhuo
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (01) : 107 - 118
12345